glp-1 logo US | The GLP-1 Podcast Show |
Description
Purpose of Review This article will review several cases demonstrating breast imaging findings following the use of glucagon-like peptide-1 (GLP-1) agonists, including the relevant implications in changing breast density and supplemental screening
Thats up 49% YoY and 155% from 2023
Continuous use of GLP-1 receptor agonists in adults with type 2 diabetes was associated with a lower risk of major cardiovascular events compared with sulfonylureas, with benefits increasing over time
$249 per month, no matter the dose
The conversation around it has grown, especially online,
